Vapotherm, Inc. (NYSE:VAPO – Get Rating) Director Anthony L. Arnerich purchased 20,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were acquired at an average cost of $1.65 per share, for a total transaction of $33,000.00. Following the acquisition, the director now owns 73,374 shares of the company's stock, valued at approximately $121,067.10. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website.
Vapotherm Stock Performance
Vapotherm stock opened at $1.80 on Friday. The company has a debt-to-equity ratio of 7.04, a quick ratio of 3.25 and a current ratio of 5.29. The firm has a market cap of $48.05 million, a price-to-earnings ratio of -0.49 and a beta of -0.22. Vapotherm, Inc. has a 1 year low of $1.62 and a 1 year high of $31.87. The firm's 50 day moving average price is $2.42 and its two-hundred day moving average price is $7.46.
Get Vapotherm alerts:Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on VAPO shares. Canaccord Genuity Group cut Vapotherm from a "buy" rating to a "hold" rating and cut their price target for the company from $12.00 to $5.00 in a report on Friday, May 6th. BTIG Research cut Vapotherm from a "buy" rating to a "neutral" rating in a report on Thursday, August 4th. William Blair cut Vapotherm from an "outperform" rating to a "market perform" rating in a report on Thursday, August 4th. Piper Sandler dropped their target price on Vapotherm from $2.50 to $2.00 and set an "underweight" rating on the stock in a report on Thursday, August 4th. Finally, Canaccord Genuity Group cut Vapotherm from a "buy" rating to a "hold" rating and dropped their target price for the stock from $12.00 to $5.00 in a report on Friday, May 6th. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $4.75.
Hedge Funds Weigh In On Vapotherm
Several institutional investors and hedge funds have recently added to or reduced their stakes in VAPO. Sawtooth Solutions LLC purchased a new position in Vapotherm during the 2nd quarter worth approximately $38,000. Private Advisor Group LLC purchased a new position in Vapotherm during the 2nd quarter worth approximately $38,000. Mayflower Financial Advisors LLC grew its position in Vapotherm by 51.2% during the 2nd quarter. Mayflower Financial Advisors LLC now owns 16,400 shares of the company's stock worth $41,000 after purchasing an additional 5,550 shares in the last quarter. Trek Financial LLC purchased a new position in Vapotherm during the 2nd quarter worth approximately $69,000. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of Vapotherm by 18.0% during the 4th quarter. BNP Paribas Arbitrage SA now owns 4,907 shares of the company's stock valued at $102,000 after buying an additional 747 shares during the period. 69.67% of the stock is currently owned by hedge funds and other institutional investors.Vapotherm Company Profile
(Get Rating)
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Further Reading
- Get a free copy of the StockNews.com research report on Vapotherm (VAPO)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.